Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SurgLine International receives letter from the SEC which closes it investigation against the Company as of May 29 2015
Newport Beach, California -- May 30, 2015 / (http://www.myprgenie.com) -- For Immediate Release For Further Information Contact:
May 29, 2015 Thomas Toland
949-698-8485 mobile
SURGLINE INTERNATIONAL, UPDATE on receiving its letter closing the investigation against the Company without enforcement action
WEST PALM BEACH, Fla. May 29, 2015 SurgLine International, Inc. (SGLN.PK)
SurgLine International, Inc. received a letter today from The United States Securities and Exchange Commission ("SEC") San Francisco Regional Office which closed its investigation against the company.
The letter stated that had not recommended enforcement against the company as of May 29 2015.
The CEO, Mr. Toland was pleased that the investigation had come to its conclusion without enforcement of any type at this date and that this brought to conclusion the long awaited chapter in the company's history commenced in the fall of 2012.
Mr. Toland was quoted as saying, "The Company fully cooperated with the Commission on this investigation and always held that it had not knowingly violated any terms or conditions that would have warranted this voluntary action in the fall of 2012."
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the "Company"). In particular, when used in the preceding discussion, the words "predicts", "believes", "expects", "intends", "seeks", "estimates", "plans", "anticipates", and similar conditional expressions or future or conditional verbs such as "will", "may", "might", "should" "would" and "could" are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, "Risk Factors" of the Company’s annual Report on Form 10-K for the year ended July 31, 2014 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
Contact: Tom Toland, tom.toland2011@gmail.com, 949 698 8485
Contact Information
Tom Toland
Newport Beach, California , United States
SurgLine International receives letter from the SEC which closes it investigation against the Company as of May 29 2015
Newport Beach, California -- May 30, 2015 / (http://www.myprgenie.com) -- For Immediate Release For Further Information Contact:
May 29, 2015 Thomas Toland
949-698-8485 mobile
SURGLINE UPDATE on letter closing investigation against the Company without enforcement action the company
WEST PALM BEACH, Fla. May 29, 2015 SurgLine International, Inc. (SGLN.PK)
SurgLine International, Inc. received a letter today which closes its investigation against it as of May 29 2015. The CEO, Mr. Toland was pleased that the investigation had come to conclusion without enforcement of any type at this date.
Please see www.sec.gov/divisions/enforce/wells-release.pdf
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the "Company"). In particular, when used in the preceding discussion, the words "predicts", "believes", "expects", "intends", "seeks", "estimates", "plans", "anticipates", and similar conditional expressions or future or conditional verbs such as "will", "may", "might", "should" "would" and "could" are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, "Risk Factors" of the Company’s annual Report on Form 10-K for the year ended July 31, 2014 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
Contact: Tom Toland, tom.toland2011@gmail.com, 9496988485
Category: Healthcare
Word Count:492
Tags: SEC
Weblinks: www.surgline.com
For Immediate Release For Further Information Contact:
April 8, 2015 Thomas Toland
949-698-8485 mobile
SURGLINE UPDATE on Biologics and Allergy SLIT testing
WEST PALM BEACH, Fla., April 8, 2015 SurgLine International, Inc. (SGLN.PK)
SurgLine International, Inc. and its wholly owned subsidiary SurgLine Inc. is waiting for the manufacturer of its Sublingual Immunotherapy product to receive its final approval of labeling. The FDA has recently issued its intent to further evaluate biologics and labeling requirements. At this point, the Company has no definitive timeframe as to the FDA’s guidance and must wait for labeling guidance.
The Company has ceased to market its surgical implant products to hospitals and surgery centers due to a lack of interest in savings by its targeted customer base when compared to traditional legacy brands in spite of costing substantially more.
Although, hospitals and surgery centers say that they desire to save money while using the Company’s products, the physician acceptance and conversion to our generic products has been difficult to establish in any meaningful manner at this point in time.
The Company concludes that the legacy companies offer such historical acceptance with the physician community that is difficult to convert from these legacy products to a more cost effective product offering.
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the "Company"). In particular, when used in the preceding discussion, the words "predicts", "believes", "expects", "intends", "seeks", "estimates", "plans", "anticipates", "concludes" and similar conditional expressions or future or conditional verbs such as "will", "may", "might", "should" "would" and "could" are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, "Risk Factors" of the Company’s annual Report on Form 10-K for the year ended July 31, 2014 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
For Immediate Release For Further Information Contact:
July 12, 2014 Thomas Toland
949-698-8485 mobile
SURGLINE UPDATE on business and filing status
WEST PALM BEACH, Fla., July 12, 2014 SurgLine International, Inc. (SGLN.PK)
SurgLine International, Inc. and its wholly owned subsidiary SurgLine Inc. is waiting for the manufacturer of its Sublingual Immunotherapy product to receive its final approval of labeling requirements from the FDA and anticipates that the approval will be forthcoming within approximately the next 14 days.
The Company will launch its sales efforts immediately following the approval process to its target market and will commence recruiting and training a sales force to penetrate the primary care marketplace.
These new revenues are anticipated to allow the company to generate new cash flow opportunities while pursuing its cost savings model for savings to surgery centers and hospitals. The Company estimates that the SLIT allergy market in the U.S. to be in excess of 1 billion dollars per year.
The Company is also in the process of interviewing potential candidates to act as its in-house CFO in anticipation of its impending launch of the Allergy program and other impending program opportunities. The candidate will have prior public company reporting experience.
Once the Company successfully recruits its new CFO candidate, it plans to use the proceeds from the Physician Allergy program to become current with its past due filings and reporting at the soonest opportunity.
The Company will continue to provide updates on material developments on both its Allergy program as well as its reporting status over the next 45 to 60 days.
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the "Company"). In particular, when used in the preceding discussion, the words "predicts", "believes", "expects", "intends", "seeks", "estimates", "plans", "anticipates", and similar conditional expressions or future or conditional verbs such as "will", "may", "might", "should" "would" and "could" are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, "Risk Factors" of the Company’s annual Report on Form 10-K for the year ended July 31, 2014 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
For Immediate Release For Further Information Contact:
June 19, 2014 Thomas Toland
949-698-8485 mobile
SURGLINE UPDATE ON ALLERGY PRODUCT LAUNCH
WEST PALM BEACH, Fla., June 19, 2014 SurgLine International, Inc. (SGLN.PK)
SurgLine International, Inc. and its wholly owned subsidiary SurgLine Inc. will launch a physician office allergy testing program using Sublingual Immunotherapy also known as SLIT.
As an update, SurgLine is awaiting final approval from the manufacturer as to final labeling requirements from the FDA for the allergy product. The manufacturer has received an expedited appointment with the FDA and is confident that it will receive the necessary approvals to launch its product offering.
SurgLine will commence its marketing of the product as soon as it is notified. The manufacturer has not given SurgLine a date specific for the intended launch until it receives the required letter.
SurgLine will provide an update as soon as it has the updated information to report.
McKesson is the registered trademark of McKesson Corporation and Henry Schein is the registered trademark of Henry Schein, Inc.
SurgLine continues to participate in the MedPassage ecosystem and anticipates that the MedPassage ecosystem will continue to gain market share awareness in the coming year to which SurgLine will benefit from sale of its products and aggressive pricing strategies.
Keywords: Henry Schein, McKesson, Medical, Dental, Veterinarian, Hospitals, Clinics, Physician, Practices, Savings, Laboratories, SurgLine, SurgLinesavings.com, Savings, direct ship.
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the "Company"). In particular, when used in the preceding discussion, the words "predicts", "believes", "expects", "intends", "seeks", "estimates", "plans", "anticipates", and similar conditional expressions or future or conditional verbs such as "will", "may", "might", "should" "would" and "could" are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, "Risk Factors" of the Company’s annual Report on Form 10-K for the year ended July 31, 2014 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
SURGLINE will expand its business model to include driving new revenues to physician practices via its launch of a physician in-office allergy testing program starting July 1, 2014.
The program will drive down the cost of care for allergy therapy in the U.S. marketplace while driving new revenues to physicians.
WEST PALM BEACH, Fla., June 2, 2014 SurgLine International, Inc. (SGLN.PK)
SurgLine International, Inc. and its wholly owned subsidiary SurgLine Inc. will launch a physician office allergy testing program using Sublingual Immunotherapy also known as SLIT commencing July 1, 2014.
• It is estimated that 58% of patients suffering from allergies visit their primary care provider first.
• 54.6% of Americans are allergic to at least two allergens.
• The supply of allergists is expected to decline while the demand for allergists is expected to continue to rise.
• Our SLIT in-office testing program will decrease the cost of allergy and asthma care by up to 80% over traditional steroid therapy.
SurgLine will be one of the first companies in the United States to launch this highly effective allergy testing and treatment program.
It is estimated that there are 300,000 plus primary care physicians practicing in the U.S. alone that can administer the SurgLine Allergy program.
It is estimated that more than 150 million people suffer from allergies and or asthma.
SurgLine will also focus on targeting managed care payers seeking to reduce the cost of allergy and asthma care that traditionally includes allergy shots and steroids.
The SurgLine Allergy program will offer patients the opportunity to administer a drop each morning under the tongue in place of allergy shots.
This therapy program will drive new revenues to primary care physicians while driving down the total cost of care. The average primary care physician can materially improve his or her practice profitability with our SLIT Allergy program.
These new revenues are anticipated to allow the company to generate new cash flow opportunities while pursuing its cost savings model for savings to surgery centers and hospitals.
McKesson is the registered trademark of McKesson Corporation and Henry Schein is the registered trademark of Henry Schein, Inc.
SurgLine continues to participate in the MedPassage ecosystem and anticipates that the MedPassage ecosystem will continue to gain market share awareness in the coming year to which SurgLine will benefit from sale of its products and aggressive pricing strategies.
Keywords: Henry Schein, McKesson, Medical, Dental, Veterinarian, Hospitals, Clinics, Physician, Practices, Savings, Laboratories, SurgLine, SurgLinesavings.com, Savings, direct ship.
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the "Company"). In particular, when used in the preceding discussion, the words "predicts", "believes", "expects", "intends", "seeks", "estimates", "plans", "anticipates", and similar conditional expressions or future or conditional verbs such as "will", "may", "might", "should" "would" and "could" are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, "Risk Factors" of the Company’s annual Report on Form 10-K for the year ended July 31, 2014 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
For Immediate Release For Further Information Contact:
June 2, 2014 Thomas Toland
949-698-8485 mobile
SURGLINE will expand its products and services effective July 1, 2014
WEST PALM BEACH, Fla., June 2, 2014 SurgLine International, Inc. (SGLN.PK)
SurgLine International, Inc. and its wholly owned subsidiary SurgLine Inc. is planning to announce and launch a diversification of its core business model to include new revenue sources.
The company intends to announce further details of the new products within the next three weeks from this announcement.
This diversification of the company’s business model will include a focus on healthcare products and services that will allow the company to derive new revenues primarily focused to physicians and medical groups.
These products and services are in high demand and the company believes it will have substantial marketing opportunities to rapidly grow its product offering.
These new revenues are anticipated to allow the company to generate new cash flow opportunities while pursuing its cost savings model for savings to surgery centers and hospitals.
McKesson is the registered trademark of McKesson Corporation and Henry Schein is the registered trademark of Henry Schein, Inc.
Keywords: Henry Schein, McKesson, Medical, Dental, Veterinarian, Hospitals, Clinics, Physician, Practices, Savings, Laboratories, SurgLine, SurgLinesavings.com, Savings, direct ship.
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the "Company"). In particular, when used in the preceding discussion, the words "predicts", "believes", "expects", "intends", "seeks", "estimates", "plans", "intends" "anticipates", "plans or is planning" and similar conditional expressions or future or conditional verbs such as "will", "may", "might", "should" "would" and "could" are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, "Risk Factors" of the Company’s annual Report on Form 10-K for the year ended July 31, 2014 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
For Immediate Release For Further Information Contact:
March 31, 2014 Thomas Toland
949-698-8485 mobile
SURGLINE renews its business license and annual list effective March 3, 2014
WEST PALM BEACH, Fla., JANUARY 13, 2014 SurgLine International, Inc. (SGLN.PK)
The company is pleased to announce that it has renewed its business license with the state of Nevada for SurgLine Inc. effective March 31, 2014.
The company is continuing its focus on marketing cost effective surgical implants and related products to its targeted customer base in the U.S. marketplace.
The company's management team believes that adoption of he industry to more cost effective solutions such as generic style pricing is a cornerstone to economic savings to the heathcare system and will continue to pursue those opportunities.
The Company’s model of eliminating unnecessary layers of sales distribution costs will afford it with the opportunity to save our customers 30% on average when compared to the traditional distribution chains while drop shipping these products directly to the customer for quick delivery.
SurgLine has begun to upload its product catalogs into this marketplace and commence sales of those items to thru www.surglinesupplies.com. SurgLine’s traditional product offering will require authentication of the end user in keeping with FDA requirements and will be incorporated into the www.surglinesupplies.com.
McKesson is the registered trademark of McKesson Corporation and Henry Schein is the registered trademark of Henry Schein, Inc.
SurgLine continues to participate in the MedPassage ecosystem and anticipates that the MedPassage ecosystem will continue to gain market share awareness in the coming year to which SurgLine will benefit from sale of its products and aggressive pricing strategies.
Keywords: Henry Schein, McKesson, Medical, Dental, Veterinarian, Hospitals, Clinics, Physician, Practices, Savings, Laboratories, SurgLine, SurgLinesavings.com, Savings, direct ship.
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the "Company"). In particular, when used in the preceding discussion, the words "predicts", "believes", "expects", "intends", "seeks", "estimates", "plans", "anticipates", and similar conditional expressions or future or conditional verbs such as "will", "may", "might", "should" "would" and "could" are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, "Risk Factors" of the Company’s annual Report on Form 10-K for the year ended July 31, 2014 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
Good morning, let me take a moment to put to rest this issue of the cloned site. The party to which originally developed mdsupplies.com and I have known each other for many years.
In order to compete, the management team of SurgLine believes it needs to market a direct online surgical implant marketplace to sell its products directly to end users in addition to medpassage.com via www.surgline.com.
We have looked at variety of alternatives and this was the best, fastest and most economical option for Surgline now.
It's built, it works, and it is what we needed to grow our online presence. Products are drop shipped directly from the manufacturers and we do not have to stock one item.
We agreed to private label the existing mdsupplies.com website as surglinesupplies.com and commence loading our existing products into the surglinesupplies.com site since they have no surgical implant strategy.
By streamlining the process surglinesupplies.com eliminates approximately 30% to 40% out of the end user sales price when compared to the traditional physician detailers like McKesson and Henry Schein.
MDSupplies has virtually NO sales force, they are developers of software.
The strategy also gives our company the ability to sell products that SurgLine does not currently represent and broaden our revenue stream opportunities with new customers.
GO SGLN
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the “Company”). In particular, when used in the preceding discussion, the words “predicts”, “believes”, “expects”, “intends”, “seeks”, “estimates”, “plans”, “anticipates”, and similar conditional expressions or future or conditional verbs such as “will”, “may”, “might”, “should” “would” and “could” are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, “Risk Factors” of the Company’s annual Report on Form 10-K for the year ended July 31, 2014 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
For Immediate Release
SURGLINE update on www.surglinesupplies.com and New Market Expansion Opportunities via its online marketplace
WEST PALM BEACH, Fla., JANUARY 13, 2014 SurgLine International, Inc. (SGLN.PK)
SURGLINE EXPANDS ITS COST SAVINGS MODEL VIA www.surglinesupplies.com tab on surgline.com’s home page to new customers via its online marketplace.
The company is pleased to announce that effective immediately; it will offer and expand its savings model of high quality surgical implants to now include similar savings of products used every day to include physician offices and clinics, assisted living centers, dental practices, and laboratories and more via www.surglinesupplies.com.
New customers can enroll and commence purchasing products immediately from the www.surgline.com website and clicking on the surglinesupplies tab.
SurgLine will offer its current surgical implant products to ambulatory surgery centers and hospitals via www.surglinesupplies.com as well.
The company’s new offering of medical disposables and other goods and services used every day will compete directly with the traditional distribution supply chains vendors such as McKesson and Henry Schein.
The Company’s model of eliminating unnecessary layers of sales distribution costs will afford it with the opportunity to save our customers 30% on average when compared to the traditional distribution chains while drop shipping these products directly to the customer for quick delivery.
The benefits to SurgLine shareholder will be to expand its depth to new customers and drive new customers directly to its website where the customer can sign up and execute transactions immediately.
The benefit to the SurgLine customer is deeper savings and quick delivery of products without the need to have a sales rep take orders in the office.
Mr. Toland was quoted as saying, “this new feature will broaden our company’s exposure, while generating new revenue sources throughout the healthcare marketplace with no additional overhead burden."
In the coming weeks, SurgLine will begin to upload its product catalogs into this marketplace and commence sales of those items to thru www.surglinesupplies.com. SurgLine’s traditional product offering will require authentication of the end user in keeping with FDA requirements and will be incorporated into the www.surglinesupplies.com.
McKesson is the registered trademark of McKesson Corporation and Henry Schein is the registered trademark of Henry Schein, Inc.
SurgLine continues to participate in the MedPassage ecosystem and anticipates that the MedPassage ecosystem will continue to gain market share awareness in the coming year to which SurgLine will benefit from sale of its products and aggressive pricing strategies.
Keywords: Henry Schein, McKesson, Medical, Dental, Veterinarian, Hospitals, Clinics, Physician, Practices, Savings, Laboratories, SurgLine, SurgLinesavings.com, Savings, direct ship.
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the “Company”). In particular, when used in the preceding discussion, the words “predicts”, “believes”, “expects”, “intends”, “seeks”, “estimates”, “plans”, “anticipates”, and similar conditional expressions or future or conditional verbs such as “will”, “may”, “might”, “should” “would” and “could” are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, “Risk Factors” of the Company’s annual Report on Form 10-K for the year ended July 31, 2014 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
For the record, I did not speak to BBSeller today or at any point in time and his post is completely fraudulent
For Immediate Release For Further Information Contact:
December 10, 2013 Thomas Toland 949-698-8485 mobile
SURGLINE update on status of business opportunities
WEST PALM BEACH, Fla., DECEMBER 10, 2013 SurgLine International, Inc. (SGLN.PK)
SURGLINE UPDATE ON STATUS OF BUSINESS OPPORTUNITIES
This update is being made to provide the shareholders of SurgLine with a brief overview of the company’s current status and focus on future business opportunities.
The Company is currently engaged in introducing its surgical product offering, which includes, spine hardware, trauma hardware, sports medicine implants for shoulder surgery, Osteobiologics and surgical blades and burs used in the operating room for orthopedic surgery, and podiatric surgery.
Its client focus includes physician owned surgery centers and hospitals seeking to reduce their cost exposure in the operating room while delivering cost effective products on behalf of their patients.
The company has recently executed an agreement to distribute surgical blades and burs used by hospitals and surgery centers throughout the United States. This market is estimated at more than $800 million annually.
This distribution agreement will expand the company’s product offering into disposable and reusable blades and burs used every day by surgery centers and hospitals at a savings of approximately 20% to 30% vs. the competition.
SurgLine continues to participate in the MedPassage ecosystem and anticipates that the MedPassage ecosystem will continue to gain market share awareness in the coming year to which SurgLine will benefit from sale of its products and aggressive pricing strategies.
The company continues to have ongoing discussions with its CPA firm and outside SEC counsel as it relates to its current filing status and is reviewing the process of what requirements will be necessary to regaining its trading status on the OTC marketplace at the earliest possible opportunity. Although the company has had no further discussions with any regulatory authority, the company believes that its business is viable and will make all reasonable efforts to the end result.
SurgLine further anticipates that in the coming calendar year its cost effective products will continue to gain market acceptance as the federal government continues to roll out its Obamacare enrollment efforts to the marketplace while enrolling millions of newly covered Americans in the program forcing hospitals and surgery centers to seek out more cost effective products.
SurgLine will additionally be focused on expanding its product offering via third-party sales representatives and distributors seeking to align themselves with cost effective products.
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the “Company”). In particular, when used in the preceding discussion, the words “predicts”, “believes”, “expects”, “intends”, “seeks”, “estimates”, “plans”, “anticipates”, and similar conditional expressions or future or conditional verbs such as “will”, “may”, “might”, “should” “would” and “could” are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, “Risk Factors” of the Company’s annual Report on Form 10-K for the year ended July 31, 2014 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
No specific POD or physician owned distributor was named in the report. If you read the report, you would have known that. If you are truly and investor, it would seem like this report would have made you stop and think for a brief moment that SurgLine is positioned to benefit from the OIG's report.
Enough said. I am not going to comment any further on this kind of posting in the future. I am too busy working on making this company something more than it is today. Thank you as always for your support. Go SGLN.
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the “Company”). In particular, when used in the preceding discussion, the words “predicts”, “believes”, “expects”, “intends”, “seeks”, “estimates”, “plans”, “anticipates”, and similar conditional expressions or future or conditional verbs such as “will”, “may”, “might”, “should” “would” and “could” are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, “Risk Factors” of the Company’s annual Report on Form 10-K for the year ended July 31, 2013 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
For Immediate Release For Further Information Contact:
October 31, 2013 Thomas Toland
949-698-8485 mobile
SURGLINE’S MARKET ASSESMENT ON THE OFFICE OF INSPECTOR GENERAL’S REPORT ON SPINAL DEVICES SUPPLIED BY PHYSICIAN-OWNED DISTRIBUTORS.
WEST PALM BEACH, Fla., OCTOBER 31, 2013 SurgLine International, Inc. (SGLN.PK)
SURGLINE’S market assessment on the Office of Inspector General’s (“OIG”) report entitled “Spinal Devices Supplied by Physician-Owned Distributors. Overview on Prevalence and Use."
SurgLine Inc. and its parent SurgLine International, Inc. have analyzed and assessed the market opportunity and future growth opportunities associated with the Office of Inspector General’s report released to the public on October 23, 2013.
In the OIG report issued last week, it is clear that on average, there is “no material” savings to the Medicare program derived by physician-owned distributors when compared to purchases of spinal hardware purchased without the use of a physician-owned distributor.
The report provided insight into actual data that was captured as part of the decision process. That report has been uploaded to our website at www.surgline.com.
SurgLine’s projected savings is on average greater than 60% when compared to the spinal implant pricing of traditional distributors in the OIG report (non-physician owned distributors).
The savings is even higher on average when compared to the prices offered by Physician owned distributors.
The Company has patiently awaited the OIG report and will use this report to demonstrate its value proposition to surgeons, hospitals and insurance companies throughout the U.S. marketplace as part of its go-forward strategy to gain traction and revenues in the future.
The tide in the healthcare marketplace is beginning to turn toward companies like SurgLine that can offer deeply discounted, high quality products at generic-style pricing with market interruptive pricing strategies.
Tom Toland was quoted as saying, “SurgLine currently offers a hospital or surgical center a polyaxial pedicle screw with set cap for $375 as compared to a non-pod distributor of $1040 for a savings of $665 each.
Typically, the surgeon implants from four to eight of these screws per surgical lumbar spine case. “
Mr. Toland went on to add, “This savings listed above does not include similar savings for PEEK interbody devices or titanium rods used in these cases with equally impressive savings potential.”
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the “Company”). In particular, when used in the preceding discussion, the words “predicts”, “believes”, “expects”, “intends”, “seeks”, “estimates”, “plans”, “anticipates”, and similar conditional expressions or future or conditional verbs such as “will”, “may”, “might”, “should” “would” and “could” are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, “Risk Factors” of the Company’s annual Report on Form 10-K for the year ended July 31, 2013 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
For Immediate Release For Further Information
Contact: Thomas Toland
October 25,2013
949-698-8485 mobile
OFFICE OF INSPECTOR GENERAL RELEASES ITS LONG AWAITED REPORT ON SPINAL DEVICES SUPPLIED BY PHYSICIAN-OWNED DISTRIBUTORS.
WEST PALM BEACH, Fla., OCTOBER 25, 2013 SurgLine International, Inc. (SGLN.PK)
On Wednesday, the Office of Inspector General (“OIG”) released its long awaited report entitled “Spinal Devices Supplied by Physician-Owned Distributors. Overview on Prevalence and Use.
SurgLine Inc. and its parent SurgLine International, Inc. engaged a healthcare law firm in the summer of 2012 to assess the business and legal issues of Physician Owned Distributors also known as POD’s. The conclusion of the executive team was not to pursue this business opportunity due to the many unknowns surrounding the fast growing POD industry.
In the report, The OIG concluded that the fact that PODs provide devices at the same or higher cost than companies not owned by physicians, combined with the increased volume of spinal surgeries performed at hospitals that purchase implants from PODs, may increase the cost of spinal surgeries to the Medicare program and beneficiaries over time.
This recent development bodes well for SurgLine as the strategy of SurgLine is to lower the cost of surgical spine implants to the insurance company including the Medicare program.
It appears that POD’s merely shifted the cost from the hospital to the POD who bills the insurance company and or Medicare with no real savings derived thereof and at the same time allowing physicians to reap the financial rewards of doing so.
SurgLine’s mission continues to be one that is committed to true hardware transparency and will work closely with patients, physicians, hospitals, surgery centers, insurance companies, managed care organizations, self-insured payers, and state and federal government payers to reduce the true cost of the surgical implants in the healthcare sector.
SurgLine will make available the entire OIG report on its website at www.surgline.com.
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the “Company”). In particular, when used in the preceding discussion, the words “predicts”, “believes”, “expects”, “intends”, “seeks”, “estimates”, “plans”, “anticipates”, and similar conditional expressions or future or conditional verbs such as “will”, “may”, “might”, “should” “would” and “could” are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, “Risk Factors” of the Company’s annual Report on Form 10-K for the year ended July 31, 2013 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
Thank you for you for the words of encouragement. I believe in what we are doing as a company. We have great products, great prices and I believe we will have our share of the business in surgical implant space.
Have a great weekend.
Speaking on behalf of the Company including myself as the CEO, we appreciate the support of all of its investors including investors like StockBullion who have expressed his criticism on the iHub investor board. At the end of the day, I believe we all desire the success of the Company and we will focus on achieving success for the future. Thank you.
Go SGLN.
Go SGLN
We are talking to people as we speak. I spoke to our CPA firm today about it.
For the record no one on this management team to my knowledge has ever lied to any shareholder on any PR since we took this company over on September 1, 2011.
All Press Releases issued by the company on the dates issued reflected what management reasonably believed to be forthcoming by the company and of course each PR included forward-looking disclosures.
And by the way, I am still here, building this company piece by piece for a strong future for all shareholders including you.
Just to set the record straight.
Tom Toland
CEO SurgLine International, Inc.
This announcement made last year by SurgLine anticipated that SJS would have the ability to continue to execute its business model that included billing for surgical cases primarily done on injured workers in the state of California.
The state of California passed legislation that went into effect a few months later, whereby the surgical implants that were previously billed for during surgery and carved out separately and reimbursed in addition to the DRG paid by the work comp insurance company were eliminated.
This reimbursement model now looks more like Medicare which forced SJS to change its strategy and thus their ability to drive business in that release became null and void.
The reimbursement world for surgical implants is changing rapidly in the State of California and elsewhere throughout the U.S.
Thank you.
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the “Company”). In particular, when used in the preceding discussion, the words “predicts”, “believes”, “expects”, “intends”, “seeks”, “estimates”, “plans”, “anticipates”, and similar conditional expressions or future or conditional verbs such as “will”, “may”, “might”, “should” “would” and “could” are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, “Risk Factors” of the Company’s annual Report on Form 10-K for the year ended August 31, 2013 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
You are welcome
Good morning. In the case of the recent sale of shoulder anchors, the gross profit was approximately 42.5%. This client is interested in purchasing the instrument set that is used as part of the rotator cuff repair which would result in additional revenue to the company. There are 10 5.5 anchors per box and there are typically 2 to 3 anchors used on a rotator cuff repair.
We also offer a consignment option. In this option, the estimated gross profit is even higher to the user and still results in average savings of 40 to 50% over the competition. SurgLine has the exclusivity for selling these products on consignment and works closely with the manufacturer to sell its products across the U.S. and beyond.
This is one of the ways that SurgLine is positioning itself to be a top choice for low cost, high quality products. This product is made in the U.S.A. and has a 510K and is the lowest price anchor on the market today that I can find in the U.S.
Thanks for your support.
Tom Toland
CEO SurgLine
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the “Company”). In particular, when used in the preceding discussion, the words “predicts”, “believes”, “expects”, “intends”, “seeks”, “estimates”, “plans”, “anticipates”, and similar conditional expressions or future or conditional verbs such as “will”, “may”, “might”, “should” “would” and “could” are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, “Risk Factors” of the Company’s annual Report on Form 10-K for the year ended August 31, 2013 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
This is Tom Toland, CEO of SurgLine and the press release was cued for release earlier.
Thank you.
Tom Toland
SurgLine is pleased to announce that it has shipped its shoulder anchor product to a medpassage.com customer this past week. The company anticipates that it will continue to grow its B2B strategy with medpassage in an effort to reduce costs.
The Company has been focusing its efforts on ambulatory surgery centers and reducing costs by marketing implants such as shoulder anchors in an effort to gain new clients. These clients are typically seeking to lower their costs.
In the case of the recent anchor purchase, the Company estimates that it saved the Surgery Center more than 50% when compared to its previous vendor relationship.
The Company will continue to market such products that are classified as "stable technology" and potentially have less physician preference.
The Company will continue to use this website to update investors from time to time.
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the “Company”). In particular, when used in the preceding discussion, the words “predicts”, “believes”, “expects”, “intends”, “seeks”, “estimates”, “plans”, “anticipates”, "focusing" and similar conditional expressions or future or conditional verbs such as “will”, “may”, “might”, “should” “would” and “could” are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, “Risk Factors” of the Company’s annual Report on Form 10-K for the year ended August 31, 2013 and in any of the Company’s other subsequent Securities and Exchange Commission filings.